News: How does the Johnson & Johnson vaccine... (The Washington Post) - Behind the headlines
In the news
Media coverage of health and science topics
How does the Johnson & Johnson vaccine work? When is it available? What to know about the new shot.
The approval of the Johnson & Johnson vaccine is good news. Here’s what you need to know.
Read more at The Washington Post
Behind the headlines
Research findings and data from the National Library of Medicine
PubMed articles
Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine
The safety and immunogenicity profiles of Ad26.COV2.S support further development of this vaccine candidate. (Funded by Johnson & Johnson and the Biomedical Advanced …
Related content
Similar articles
People also viewed
Also of interest
Additional recent and related news
Johnson & Johnson Expects Vaccine Results Soon but Lags in Production
The U.S. needs J.&J.’s one-shot vaccine more than ever. But the company is behind on manufacturing promises made in its Operation Warp Speed contract.
F.D.A. Expert Panel Endorses Johnson & Johnson’s Vaccine
With this last hurdle cleared, formal authorization of the one-dose vaccine is expected on Saturday and distribution within days.
Why the Vaccine Safety Numbers Are Still Fuzzy
Putting a risk in context: The rate of blood clots is extremely low, but the pause in the Johnson & Johnson vaccine could reveal more cases.
Johnson & Johnson’s Coronavirus Vaccine Protects Monkeys, Study Finds
It’s the second study in a week to report promising results in monkeys for a vaccine candidate. But the real test will come with human trials that are now underway.
A Vaccine Can Be Bad for a Person but Awesome for All People
The safety pause in giving the Johnson & Johnson Covid-19 vaccine is up for debate again—a battle in a Secret War of Denominators and risk-benefit philosophies.